SPL 0.00% 9.7¢ starpharma holdings limited

Ann: DEP docetaxel positive phase 1 results, phase 2 commences, page-123

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 54 Posts.
    Below is  all the docxetacel - nanoparticles phase 1 in literature I could find in database. DEP_DOX is in the top of pyramid (Sorry do not have time to summarize into table, but all of them still have side effect at some stage)

    http://adisinsight.springer.com/drugs/800025017 ( Discontinued - it is similar to Abraxane - First approved nanodrug)
    https://www.ncbi.nlm.nih.gov/pubmed/25304209

    https://www.ncbi.nlm.nih.gov/pubmed/23274395
    http://europepmc.org/articles/PMC5363590;jsessionid=775FC273CB90CCD53A214EFE9F0875EF
    https://www.ncbi.nlm.nih.gov/pubmed/26847057
    http://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2526
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.